Synopsis
0
CEP/COS
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - EQ 2GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50684
DOSAGE - INJECTABLE;INJECTION - EQ 36GM BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50684
DOSAGE - INJECTABLE;INJECTION - EQ 3GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50684
DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/V...DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50684
DOSAGE - INJECTABLE;INJECTION - EQ 40MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML
USFDA APPLICATION NUMBER - 50750
DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/1...DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML
USFDA APPLICATION NUMBER - 50750
DOSAGE - INJECTABLE;INJECTION - EQ 60MG BASE/...DOSAGE - INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML
USFDA APPLICATION NUMBER - 50750
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Fillers, Diluents & Binders
Thickeners and Stabilizers
API Stability Enhancers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
19
PharmaCompass offers a list of Tazobactam Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tazobactam Sodium manufacturer or Tazobactam Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tazobactam Sodium manufacturer or Tazobactam Sodium supplier.
PharmaCompass also assists you with knowing the Tazobactam Sodium API Price utilized in the formulation of products. Tazobactam Sodium API Price is not always fixed or binding as the Tazobactam Sodium Price is obtained through a variety of data sources. The Tazobactam Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ZOSYN IN PLASTIC CONTAINER-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ZOSYN IN PLASTIC CONTAINER-1, including repackagers and relabelers. The FDA regulates ZOSYN IN PLASTIC CONTAINER-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ZOSYN IN PLASTIC CONTAINER-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ZOSYN IN PLASTIC CONTAINER-1 supplier is an individual or a company that provides ZOSYN IN PLASTIC CONTAINER-1 active pharmaceutical ingredient (API) or ZOSYN IN PLASTIC CONTAINER-1 finished formulations upon request. The ZOSYN IN PLASTIC CONTAINER-1 suppliers may include ZOSYN IN PLASTIC CONTAINER-1 API manufacturers, exporters, distributors and traders.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ZOSYN IN PLASTIC CONTAINER-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of ZOSYN IN PLASTIC CONTAINER-1 active pharmaceutical ingredient (API) in detail. Different forms of ZOSYN IN PLASTIC CONTAINER-1 DMFs exist exist since differing nations have different regulations, such as ZOSYN IN PLASTIC CONTAINER-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ZOSYN IN PLASTIC CONTAINER-1 DMF submitted to regulatory agencies in the US is known as a USDMF. ZOSYN IN PLASTIC CONTAINER-1 USDMF includes data on ZOSYN IN PLASTIC CONTAINER-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ZOSYN IN PLASTIC CONTAINER-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The ZOSYN IN PLASTIC CONTAINER-1 Drug Master File in Japan (ZOSYN IN PLASTIC CONTAINER-1 JDMF) empowers ZOSYN IN PLASTIC CONTAINER-1 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the ZOSYN IN PLASTIC CONTAINER-1 JDMF during the approval evaluation for pharmaceutical products. At the time of ZOSYN IN PLASTIC CONTAINER-1 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ZOSYN IN PLASTIC CONTAINER-1 Drug Master File in Korea (ZOSYN IN PLASTIC CONTAINER-1 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ZOSYN IN PLASTIC CONTAINER-1. The MFDS reviews the ZOSYN IN PLASTIC CONTAINER-1 KDMF as part of the drug registration process and uses the information provided in the ZOSYN IN PLASTIC CONTAINER-1 KDMF to evaluate the safety and efficacy of the drug.
After submitting a ZOSYN IN PLASTIC CONTAINER-1 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ZOSYN IN PLASTIC CONTAINER-1 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with KDMF on PharmaCompass.
A ZOSYN IN PLASTIC CONTAINER-1 written confirmation (ZOSYN IN PLASTIC CONTAINER-1 WC) is an official document issued by a regulatory agency to a ZOSYN IN PLASTIC CONTAINER-1 manufacturer, verifying that the manufacturing facility of a ZOSYN IN PLASTIC CONTAINER-1 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting ZOSYN IN PLASTIC CONTAINER-1 APIs or ZOSYN IN PLASTIC CONTAINER-1 finished pharmaceutical products to another nation, regulatory agencies frequently require a ZOSYN IN PLASTIC CONTAINER-1 WC (written confirmation) as part of the regulatory process.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ZOSYN IN PLASTIC CONTAINER-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ZOSYN IN PLASTIC CONTAINER-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ZOSYN IN PLASTIC CONTAINER-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ZOSYN IN PLASTIC CONTAINER-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ZOSYN IN PLASTIC CONTAINER-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ZOSYN IN PLASTIC CONTAINER-1 suppliers with NDC on PharmaCompass.
ZOSYN IN PLASTIC CONTAINER-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ZOSYN IN PLASTIC CONTAINER-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ZOSYN IN PLASTIC CONTAINER-1 GMP manufacturer or ZOSYN IN PLASTIC CONTAINER-1 GMP API supplier for your needs.
A ZOSYN IN PLASTIC CONTAINER-1 CoA (Certificate of Analysis) is a formal document that attests to ZOSYN IN PLASTIC CONTAINER-1's compliance with ZOSYN IN PLASTIC CONTAINER-1 specifications and serves as a tool for batch-level quality control.
ZOSYN IN PLASTIC CONTAINER-1 CoA mostly includes findings from lab analyses of a specific batch. For each ZOSYN IN PLASTIC CONTAINER-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ZOSYN IN PLASTIC CONTAINER-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (ZOSYN IN PLASTIC CONTAINER-1 EP), ZOSYN IN PLASTIC CONTAINER-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ZOSYN IN PLASTIC CONTAINER-1 USP).
